A Study of Multiple Dosing Regimens of IV Conivaptan in Subjects With Euvolemic or Hypervolemic Hyponatremia

Completed · Phase 4 · Has a placebo group

Conditions studied: Hyponatremia, Euvolemia, Hypervolemia

In brief

The study will evaluate the effectiveness and safety of multiple dosing regimens of IV conivaptan in subjects with euvolemic or hypervolemic hyponatremia

Key facts

Study ID

NCT00435591

Run by

Cumberland Pharmaceuticals

People needed

121

Starts

2007-01-01

Expected to finish

2008-09-01

Last updated by the study team

2014-05-15

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Subject has a serum sodium value between 115 and 133 mEq/L
• Subject is euvolemic or hypervolemic

You may not qualify if…

• Clinical evidence of volume depletion or dehydration
• Uncontrolled brady- or tachyarrhythmias requiring emergent pacemaker placement or treatment

Where it is running

• Study site — Charleston, South Carolina, United States
• Study site — Bangalore, India
• Study site — Bangalore, India
• Study site — Bhopal, India
• Study site — Hyderabaad, India
• Study site — Karnāl, India
• Study site — Afula, Israel
• Study site — Ashkelon, Israel
• Study site — Haifa, Israel
• Study site — Haifa, Israel
• Study site — Holon, Israel
• Study site — Jerusalem, Israel
• Study site — Jerusalem, Israel
• Study site — Rehovot, Israel
• Study site — Safed, Israel
• Study site — Tel Aviv, Israel
• Study site — Tel Litwinsky, Israel
• Study site — Ẕerifin, Israel

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.